rs184003
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_001136.5(AGER):c.822+49G>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0946 in 1,601,932 control chromosomes in the GnomAD database, including 10,864 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (no stars).
Frequency
Genomes: 𝑓 0.12 ( 1579 hom., cov: 32)
Exomes 𝑓: 0.091 ( 9285 hom. )
Consequence
AGER
NM_001136.5 intron
NM_001136.5 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.113
Publications
88 publications found
Genes affected
AGER (HGNC:320): (advanced glycosylation end-product specific receptor) The advanced glycosylation end product (AGE) receptor encoded by this gene is a member of the immunoglobulin superfamily of cell surface receptors. It is a multiligand receptor, and besides AGE, interacts with other molecules implicated in homeostasis, development, and inflammation, and certain diseases, such as diabetes and Alzheimer's disease. Many alternatively spliced transcript variants encoding different isoforms, as well as non-protein-coding variants, have been described for this gene (PMID:18089847). [provided by RefSeq, May 2011]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.81).
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.245 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| AGER | NM_001136.5 | c.822+49G>T | intron_variant | Intron 7 of 10 | ENST00000375076.9 | NP_001127.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.124 AC: 18893AN: 152074Hom.: 1574 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
18893
AN:
152074
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.124 AC: 29835AN: 241434 AF XY: 0.133 show subpopulations
GnomAD2 exomes
AF:
AC:
29835
AN:
241434
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0915 AC: 132632AN: 1449740Hom.: 9285 Cov.: 34 AF XY: 0.0987 AC XY: 70967AN XY: 719306 show subpopulations
GnomAD4 exome
AF:
AC:
132632
AN:
1449740
Hom.:
Cov.:
34
AF XY:
AC XY:
70967
AN XY:
719306
show subpopulations
African (AFR)
AF:
AC:
6750
AN:
33196
American (AMR)
AF:
AC:
3890
AN:
44040
Ashkenazi Jewish (ASJ)
AF:
AC:
4886
AN:
25640
East Asian (EAS)
AF:
AC:
5109
AN:
39456
South Asian (SAS)
AF:
AC:
25272
AN:
85514
European-Finnish (FIN)
AF:
AC:
2640
AN:
52126
Middle Eastern (MID)
AF:
AC:
1498
AN:
5706
European-Non Finnish (NFE)
AF:
AC:
75779
AN:
1104342
Other (OTH)
AF:
AC:
6808
AN:
59720
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.485
Heterozygous variant carriers
0
6810
13619
20429
27238
34048
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
3070
6140
9210
12280
15350
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.124 AC: 18930AN: 152192Hom.: 1579 Cov.: 32 AF XY: 0.127 AC XY: 9449AN XY: 74412 show subpopulations
GnomAD4 genome
AF:
AC:
18930
AN:
152192
Hom.:
Cov.:
32
AF XY:
AC XY:
9449
AN XY:
74412
show subpopulations
African (AFR)
AF:
AC:
8417
AN:
41496
American (AMR)
AF:
AC:
1807
AN:
15306
Ashkenazi Jewish (ASJ)
AF:
AC:
717
AN:
3470
East Asian (EAS)
AF:
AC:
791
AN:
5172
South Asian (SAS)
AF:
AC:
1237
AN:
4820
European-Finnish (FIN)
AF:
AC:
483
AN:
10614
Middle Eastern (MID)
AF:
AC:
73
AN:
294
European-Non Finnish (NFE)
AF:
AC:
4976
AN:
67998
Other (OTH)
AF:
AC:
348
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
789
1578
2367
3156
3945
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
214
428
642
856
1070
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
835
AN:
3478
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: no assertion criteria provided
LINK: link
Submissions by phenotype
COPD, severe early onset Uncertain:1
Aug 10, 2023
HLA Laboratory, Instituto Nacional de Enfermedades Respiratorias Ismael Cosio Villegas
Significance:Uncertain significance
Review Status:no assertion criteria provided
Collection Method:research
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.